| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
CYH
Community Health
|
Oct 30, 2026 | BUY |
Sell
+66.3% avg upside
20 analysts
|
$3.50
45.82% Upside
|
-15.8% | Β· |
|
ENSG
The Ensign Group
|
Oct 29, 2026 | BUY |
Strong Buy
-6.9% avg upside
9 analysts
|
$215.00
18.41% Upside
|
-0.2% | Β· |
|
CHE
Chemed
|
Oct 29, 2026 | BUY |
Strong Buy
+14.3% avg upside
6 analysts
|
$625.00
16.96% Upside
|
+1.5% | Β· |
|
HCSG
Healthcare Services
|
Oct 22, 2026 | BUY |
Strong Buy
+1.5% avg upside
13 analysts
|
$28.00
14.16% Upside
|
+0.3% | Β· |
|
HUM
Humana
|
Oct 09, 2026 | BUY |
Strong Buy
+5.9% avg upside
34 analysts
|
$475.00
14.51% Upside
|
+7.0% | Β· |
|
CI
Cigna
|
Oct 01, 2026 | BUY |
Strong Buy
+15.7% avg upside
30 analysts
|
$365.00
22.41% Upside
|
+12.0% | Β· |
|
ASTH
Astrana Health
|
Sep 15, 2026 | BUY |
Strong Buy
+53.1% avg upside
17 analysts
|
$53.00
45.16% Upside
|
-16.6% | Β· |
|
PACS
PACS Group Inc
|
Aug 10, 2026 | BUY |
Strong Buy
+3.3% avg upside
9 analysts
|
$57.00
19.18% Upside
|
+0.2% | Β· |
|
EVH
Evolent Health
|
Aug 07, 2026 | BUY |
Strong Buy
+125.9% avg upside
19 analysts
|
$6.00
39.44% Upside
|
+17.0% | Β· |
|
GRDN
Guardian Pharmacy Services, Inc. Class A
|
Aug 07, 2026 | BUY |
Strong Buy
+8.6% avg upside
8 analysts
|
$49.00
20.46% Upside
|
+14.8% | Β· |
|
TDOC
Teladoc
|
Aug 04, 2026 | BUY |
Buy
+241.7% avg upside
38 analysts
|
$7.00
17.71% Downside
|
+26.5% | Β· |
|
HCA
HCA Healthcare
|
Jul 27, 2026 | BUY |
Buy
-11.8% avg upside
37 analysts
|
$485.00
2.48% Upside
|
+28.9% | Β· |
|
UNH
UnitedHealth
|
Jul 17, 2026 | BUY |
Strong Buy
+12.6% avg upside
36 analysts
|
$500.00
22.83% Upside
|
-2.7% | Β· |
|
PNTG
Pennant Group
|
May 08, 2026 | BUY |
Strong Buy
-11.2% avg upside
9 analysts
|
$40.00
3.99% Downside
|
+1.7% | Β· |
|
ADUS
Addus Homecare
|
May 06, 2026 | BUY |
Strong Buy
+2.4% avg upside
19 analysts
|
$155.00
23.54% Upside
|
+25.8% | Β· |
|
CNC
Centene
|
Apr 29, 2026 | BUY |
Buy
+7.4% avg upside
29 analysts
|
$58.00
15.33% Downside
|
+34.4% | Β· |
|
CVS
CVS Health
|
Aug 09, 2024 | HOLD |
Strong Buy
+19.5% avg upside
39 analysts
|
β | +20.0% | Β· |
|
UPHL
UpHealth
|
Mar 02, 2023 | BUY |
Strong Buy
+4024900.0% avg upside
6 analysts
|
$3.00
1499900.05% Upside
|
Β· | Β· |
|
CG
Carlyle Group
|
Feb 09, 2018 | BUY |
Buy
+30.7% avg upside
26 analysts
|
$35.00
12.93% Downside
|
-13.4% | Β· |
|
ELV
Elevance Health
|
Jun 07, 2017 | HOLD |
Strong Buy
+10.7% avg upside
33 analysts
|
β | +23.5% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.